Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSL | P07711 | 2/20 | 0.74 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.71 |
| ▸ | TUBB | P07437 | 1/20 | 0.71 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.71 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.71 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.71 |
| ▸ | TUBB4B | P68371 | 1/20 | 0.71 |
| ▸ | TUBB3 | Q13509 | 1/20 | 0.71 |
| ▸ | TUBB2A | Q13885 | 1/20 | 0.71 |
| ▸ | TUBB8 | Q3ZCM7 | 1/20 | 0.71 |
| ▸ | TUBA3E | Q6PEY2 | 1/20 | 0.71 |
| ▸ | TUBA1A | Q71U36 | 1/20 | 0.71 |
| ▸ | TUBA1C | Q9BQE3 | 1/20 | 0.71 |
| ▸ | TUBB6 | Q9BUF5 | 1/20 | 0.71 |
| ▸ | TUBB2B | Q9BVA1 | 1/20 | 0.71 |
| ▸ | TUBB1 | Q9H4B7 | 1/20 | 0.71 |
| ▸ | CALM1 | P0DP23 | 2/20 | 0.70 |
| ▸ | MEN1 | O00255 | 4/20 | 0.69 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.69 |
| ▸ | ABCG2 | Q9UNQ0 | 2/20 | 0.69 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30383389 | 1.00 | CTSL (0.74) | CTSLTUBB4ATUBBTUBA3CTUBA1B | |
| SCHEMBL30266667 | 0.99 | CTSL (0.76) | CTSLTUBB4ATUBBTUBA3CTUBA1B | |
| SCHEMBL25184983 | 0.99 | CTSL (0.76) | CTSLTUBB4ATUBBTUBA3CTUBA1B | |
| SCHEMBL25197210 | 0.99 | CTSL (0.76) | CTSLTUBB4ATUBBTUBA3CTUBA1B | |
| SCHEMBL30383942 | 0.99 | CTSL (0.76) | CTSLTUBB4ATUBBTUBA3CTUBA1B | |
| SCHEMBL25196076 | 0.94 | TUBB1 (0.79) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL30384079 | 0.94 | TUBB1 (0.79) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL25196870 | 0.89 | CXCL12 (0.80) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL25221438 | 0.89 | TUBB1 (0.71) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL25230917 | 0.89 | CXCL12 (0.80) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260014100-A1 | Compositions and Methods for Treating Bleeding and Bleeding Disorders | YEWSAVIN INC (US) | 2026-01-15 | — | — | US | disclosed |
| US-12343317-B2 | Compositions and methods for treating bleeding and bleeding disorders | YewSavin, Inc. (US) | 2025-07-01 | — | — | US | disclosed |
| US-20230190679-A1 | COMPOSITIONS AND METHODS FOR TREATING BLEEDING AND BLEEDING DISORDERS | YewSavin, Inc. (US) | 2023-06-22 | — | — | US | disclosed |
| WO-2023086388-A1 | COMPOSITIONS AND METHODS FOR TREATING BLEEDING AND BLEEDING DISORDERS | YewSavin, Inc. (US) | 2023-05-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260014100-A1 | Compositions and Methods for Treating Bleeding and Bleeding Disorders | SERPINC1, F2, F13B | CTSL 357/4885TUBB4A 3280/4885TUBB 2775/4885 |
| US-20230190679-A1 | COMPOSITIONS AND METHODS FOR TREATING BLEEDING AND BLEEDING DISORDERS | SERPINC1, SERPINE1, SERPINH1 | CTSL 310/4885TUBB4A 2584/4885TUBB 2272/4885 |
| US-12343317-B2 | Compositions and methods for treating bleeding and bleeding disorders | SERPINC1, SERPINE1, SERPINH1 | CTSL 310/4885TUBB4A 2584/4885TUBB 2272/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.